Provided by Tiger Trade Technology Pte. Ltd.

First Advantage Corp.

10.69
-0.2800-2.55%
Post-market: 10.690.00000.00%18:03 EDT
Volume:2.28M
Turnover:24.60M
Market Cap:1.86B
PE:-53.17
High:11.15
Open:11.01
Low:10.63
Close:10.97
52wk High:19.01
52wk Low:8.82
Shares:174.11M
Float Shares:79.82M
Volume Ratio:1.72
T/O Rate:2.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2011
EPS(LYR):-0.2011
ROE:-2.66%
ROA:2.13%
PB:1.42
PE(LYR):-53.17

Loading ...

First Advantage Corp Q3 revenue beats estimates

Reuters
·
Nov 06, 2025

BRIEF-First Advantage Q3 Revenue USD 409.2 Million Vs. IBES Estimate USD 404.5 Million

Reuters
·
Nov 06, 2025

First Advantage Q3 Cash Flow From Operations USD 72.4 Million

THOMSON REUTERS
·
Nov 06, 2025

First Advantage Q3 Adjusted EPS USD 0.3 VS. Ibes Estimate USD 0.28

THOMSON REUTERS
·
Nov 06, 2025

First Advantage Outlook FY Adj EPS USD 0.98 - 1.02

THOMSON REUTERS
·
Nov 06, 2025

First Advantage Reports Third Quarter 2025 Results

GlobeNewswire
·
Nov 06, 2025

Press Release: Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results

Dow Jones
·
Nov 06, 2025

Press Release: Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights

Dow Jones
·
Nov 05, 2025

Larimar Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 05, 2025

First Advantage Corporation to Participate in J.P. Morgan Ultimate Services Investor Conference

Reuters
·
Nov 05, 2025

Solid Biosciences to Participate at Upcoming Investor Conferences

GlobeNewswire
·
Oct 30, 2025

Press Release: Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters' Option to Purchase Additional Shares in the Public Offering

Dow Jones
·
Oct 21, 2025

3 Stocks Including Extreme Networks Estimated Below Fair Value

Simply Wall St.
·
Oct 21, 2025

Analysts Offer Insights on Industrial Goods Companies: First Advantage (FA) and Generac Holdings (GNRC)

TIPRANKS
·
Oct 20, 2025

First Advantage Corporation to Announce Third Quarter 2025 Financial Results

Reuters
·
Oct 16, 2025

First Advantage Named to Newsweek’s World’s Most Trustworthy Companies 2025 List

GlobeNewswire
·
Oct 15, 2025

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

GlobeNewswire
·
Oct 14, 2025

Solid Biosciences to Present at Upcoming Scientific Meetings

GlobeNewswire
·
Oct 01, 2025

Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study

Benzinga_recent_news
·
Sep 29, 2025

Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia

GlobeNewswire
·
Sep 29, 2025